Craig Thompson

Craig Thompson is the Chief Executive Officer of Cerevance, a clinical-stage drug discovery and development company focused on developing novel therapeutics for central nervous system (CNS) diseases.12 Here are some key details about Craig Thompson:

Professional Experience

• Appointed CEO of Cerevance in April 20225
• Over 25 years of experience in the pharmaceutical and biotechnology industries34
• Prior to Cerevance, he served as:
  • President and CEO of Neurana Pharmaceuticals (2018-2022)5
  • President and CEO of Anthera Pharmaceuticals (2016-2018)5
  • Chief Operating Officer at Tetraphase Pharmaceuticals (2014-2015)5
  • Chief Commercial Officer at Trius Therapeutics (2011-2014)5

Career History

• Spent 8 years at Pfizer, ultimately becoming Vice President of Marketing for Specialty Care35
• Held various roles at Merck & Co., including marketing positions for products like Vytorin, Zetia, and Zocor5

Education

• MBA from the University of Notre Dame - Mendoza College of Business35
• Bachelor of Commerce from McMaster University35

Current Roles

In addition to his position as CEO at Cerevance, Craig Thompson also serves as a Board Member for NervGen Pharma Corp. since April 2022.5

Craig Thompson brings extensive experience in drug development, commercialization, and leadership in both large pharmaceutical companies and smaller biotech firms to his role at Cerevance.14